Advertisement

Topics

Osteoporosis medications improve bone health in men with prostate cancer receiving androgen deprivation therapy

18:03 EDT 7 Aug 2017 | ecancermedicalscience

Both biophosphonates and denosumab improve bone mineral density (BMD) in men with nonmetastatic prostate cancer who are receiving androgen deprivation therapy (ADT). The results from a systematic review and meta-analysis are published in Annals of...

Original Article: Osteoporosis medications improve bone health in men with prostate cancer receiving androgen deprivation therapy

NEXT ARTICLE

More From BioPortfolio on "Osteoporosis medications improve bone health in men with prostate cancer receiving androgen deprivation therapy"

Quick Search
Advertisement
 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...